PETALING JAYA: IHH Healthcare Bhd
said the stronger ringgit was partly responsible for the 28% drop in earnings figure to RM528mil in its final quarter ended Dec 31, 2025 (4Q25) versus RM732mil in 4Q24.
Revenue eased 2% year-on-year (y-o-y) to RM6.6bil for the hospital operator and would have been 20% higher if not for the translation impact. Net profit for the quarter would have matched the 4Q24 earnings number as well.
The appreciation of the ringgit in 2025 meant IHH's financial year 2025 (FY25) net profit eased 21% y-o-y to RM2.1bil or earning per share of 23.8 sen. Revenue for the full year however, managed to rise 6% y-o-y to RM25.7bil.
Operationally its businesses in Malaysia and India performed well, driven by factors like medical tourism in the former and integration between Fortis Healthcare and Gleneagles India for the latter.
IHH’s Singapore operations remained resilient as Mount Elizabeth Orchard has reached an
inflexion point to ramp up its operations by the second half of this year. Gleneagles Hong Kong achieved breakeven in December on the back of higher inpatient volumes and revenue intensity.
In a release, IHH noted prospects for 2026 were good with its Türkiye operations to sustain market leadership and drive operational resilience while the Malaysian business will continue to grow its daycare volumes, while managing payor pressure and medical inflation with more efficient care, to deliver clinical and service excellence.
In India, the Fortis and Gleneagles brands are expected to extract more clinical and operational synergies.
IHH announced a higher dividend of 10.5 sen per share for FY25 versus 10 sen in FY24.It is also targeting double-digit returns on equity by 2028.
